← All companies

IBIO

iBio, Inc.

IBIO Nasdaq Pharmaceutical Preparations EDGAR ↗

$1.46

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$72.5M

Revenue (TTM)

$300K

Net income (TTM)

-$27.6M

EPS (TTM)

$-0.58

P/E ratio

—

Dividend yield

—

Free cash flow

-$15.3M

Cash

$47.6M

Total assets

$85.8M

Gross margin

722.3%

52-week range

$0.56 – $3.82

Recent SEC filings

40 most recent

Annual, quarterly & current reports

8-K Director or officer change; Other events Aug 4, 2026 8-K Item 5.08; Other events Jul 17, 2026 8-K Regulation FD disclosure; Other events Jul 1, 2026 10-Q Quarter ended 2026-03-31 May 12, 2026 8-K Results of operations (earnings release) May 12, 2026 8-K Director or officer change; Regulation FD disclosure May 8, 2026 8-K/A Other events Apr 17, 2026 8-K Regulation FD disclosure; Other events Apr 8, 2026 8-K Regulation FD disclosure; Other events Mar 9, 2026 8-K Entered a material agreement; Terminated a material agreement Feb 27, 2026 10-Q Quarter ended 2025-12-31 Feb 10, 2026 8-K Results of operations (earnings release) Feb 10, 2026 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 12, 2026 8-K Shareholder vote results Nov 21, 2025 8-K Regulation FD disclosure; Other events Nov 17, 2025 10-Q/A Quarter ended 2025-09-30 Nov 17, 2025 10-Q Quarter ended 2025-09-30 Nov 12, 2025 8-K Results of operations (earnings release) Nov 12, 2025 8-K Other events Nov 4, 2025 8-K Regulation FD disclosure; Other events Oct 30, 2025 10-K Fiscal year ended 2025-06-30 Sep 5, 2025 8-K Results of operations (earnings release) Sep 5, 2025 8-K Entered a material agreement; Regulation FD disclosure Aug 21, 2025 8-K Results of operations (earnings release); Other events Aug 18, 2025 8-K Delisting notice or listing-rule failure Aug 1, 2025 8-K Regulation FD disclosure; Other events Jun 24, 2025 8-K Other events Jun 18, 2025 10-Q Quarter ended 2025-03-31 May 2, 2025 8-K Results of operations (earnings release) May 2, 2025 8-K Entered a material agreement; Regulation FD disclosure Apr 22, 2025 8-K Regulation FD disclosure; Other events Apr 8, 2025 8-K Regulation FD disclosure; Other events Apr 7, 2025 8-K Delisting notice or listing-rule failure; Regulation FD disclosure Feb 19, 2025 10-Q Quarter ended 2024-12-31 Feb 10, 2025 8-K Results of operations (earnings release) Feb 10, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jan 13, 2025 8-K Regulation FD disclosure; Other events Jan 10, 2025 8-K Entered a material agreement; Unregistered sale of equity; Regulation FD disclosure Jan 2, 2025 8-K Results of operations (earnings release); Shareholder vote results Nov 25, 2024 10-Q Quarter ended 2024-09-30 Nov 12, 2024